These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 8856259

  • 1. Lipoprotein derangement during steroid treatment in minimal-change nephrotic syndrome.
    Tsukamoto Y, Kokubo T, Horii A, Moriya R, Kobayashi Y.
    Nephron; 1996; 73(4):606-12. PubMed ID: 8856259
    [Abstract] [Full Text] [Related]

  • 2. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
    Vaziri ND.
    Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
    [Abstract] [Full Text] [Related]

  • 3. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M.
    N Engl J Med; 1990 Aug 30; 323(9):579-84. PubMed ID: 2381443
    [Abstract] [Full Text] [Related]

  • 4. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND, Liang KH.
    Circulation; 2004 Jul 27; 110(4):419-25. PubMed ID: 15262831
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J, Bar-On H, Shafrir E.
    Isr J Med Sci; 1981 Nov 27; 17(11):1001-8. PubMed ID: 7319786
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of serum lipid abnormalities in chronic nephritis.
    Hirano H, Yamada Y, Otani H, Kodama N, Mune M, Yukawa S.
    Kidney Int Suppl; 1999 Jul 27; 71():S147-9. PubMed ID: 10412761
    [Abstract] [Full Text] [Related]

  • 8. Abnormalities in plasma lipoprotein in familial partial lecithin:cholesterol acyltransferase deficiency.
    Kodama T, Akanuma Y, Okazaki M, Aburatani H, Itakura H, Takahashi K, Sakuma M, Takaku F, Hara I.
    Biochim Biophys Acta; 1983 Aug 01; 752(3):407-15. PubMed ID: 6871236
    [Abstract] [Full Text] [Related]

  • 9. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C, Lisch HJ, Drexel H, Braunsteiner H.
    Schweiz Med Wochenschr; 1983 Jun 25; 113(25):909-13. PubMed ID: 6612272
    [Abstract] [Full Text] [Related]

  • 10. Lipid and lipoprotein abnormalities in renal disease.
    Segura R, Gotto AM.
    Perspect Nephrol Hypertens; 1976 Jun 25; 3():159-200. PubMed ID: 814531
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
    Lijnen P, Celis H, Desager JP, Fagard R.
    J Hum Hypertens; 1995 Jul 25; 9(7):557-64. PubMed ID: 7562885
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
    Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ.
    Kidney Int; 2000 Sep 25; 58(3):1238-46. PubMed ID: 10972686
    [Abstract] [Full Text] [Related]

  • 15. Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome.
    Tarugi P, Nicolini S, Albertazzi L, Calandra S, Salvati P, Ferti C, Patrono C.
    J Lipid Res; 1991 Oct 25; 32(10):1675-87. PubMed ID: 1797947
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A, Sobbrio GA, D'Arrigo F, Barillari M, Curasì MP, Egitto M, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Oct 25; 21(3):143-6. PubMed ID: 2149913
    [Abstract] [Full Text] [Related]

  • 19. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Oct 25; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.